Novel acylated insulin analog

Novel acylated insulin analogs, formed by a specific acylation reaction, address the need for less frequent insulin injections by offering a once-weekly administration with improved glucose control and compliance.

JP7948968B2Active Publication Date: 2026-11-11SUNSHINE LAKE PHARMA CO LTD
View PDF 12 Cites 0 Cited by

Patent Information

Application Number
JP2023572618
Authority / Receiving Office
JP · JP
Patent Type
Patents
Current Assignee / Owner
Priority Date
2021-05-24
Filing Date
2022-05-23
Publication Date
2026-11-11
Estimated Expiration
2042-05-23

AI Technical Summary

Technical Problem

Current insulin therapies require frequent injections, causing discomfort and low patient compliance, and existing insulin analogs do not provide an ideal duration of action for less frequent administration.

Method used

Development of novel acylated insulin analogs through an acylation reaction between a side-chain compound and a human insulin analog, incorporating specific fatty acid and diamino compounds, forming amide bonds, to create a longer-acting insulin preparation.

Benefits of technology

The acylated insulin analogs offer a once-weekly administration option, improving patient compliance and providing effective glucose control with a longer duration of action compared to current preparations.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 0007948968000067
    Figure 0007948968000067
  • Figure 0007948968000068
    Figure 0007948968000068
  • Figure 0007948968000069
    Figure 0007948968000069
Patent Text Reader

Abstract

It provides novel acylated insulin analogs, specifically side chain compounds that can be used to prepare acylated insulin analogs, acylated insulin analogs and their pharmaceutical compositions, medical uses, administration methods and preparation methods. The acylated insulin analogs can be used for the treatment of diabetes. It has the effect of a once-weekly preparation or a long-acting insulin preparation, and can be used for treatment once a week or less frequently, which enhances the compliance of diabetic patients.
Need to check novelty before this filing date? Find Prior Art

Citation Information

Patent Citations

  • Novel derivative of an insulin analogue

    CN105636979A

  • Insulin analog having acyl and alkylene glycol moieties

    JP2010535851A

  • Protease-stabilized acylated insulin analog

    JP2011515358A

  • Methods for acylation of peptides or proteins

    JP2012502083A

  • Human insulin analogs and their acylated derivatives

    JP2015501819A